GSTM1 and endothelial dysfunction: The improved Hb levels relatively have been explained to inhibit sickle red cell-mediated coagulation hyperactivation and endothelial dysfunction that could potentiate vascular damage, inflammation, and thrombosis resulting in various forms of sickle cell crisis [44, 45].